01 1Sinopharm Weiqida Pharmaceutical Co Ltd
01 1CLAVULANATE POTASSIUM, USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-10-06
Pay. Date : 2014-03-31
DMF Number : 27903
Submission : 2014-02-05
Status : Active
Type : II
20
Sinopharm Weiqida Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CLAVULANATE POTASSIUM, USP, with a corresponding US DMF Number 27903.
Remarkably, this DMF maintains an Active status since its submission on February 05, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 06, 2014, and payment made on March 31, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
